Tech Company Financing Transactions

Soft Tissue Regeneration Funding Round

Soft Tissue Regeneration closed a $1.5 million financing round on 12/7/2016. Backers included private investors.

Transaction Overview

Announced On
12/7/2016
Transaction Type
Venture Equity
Amount
$1,485,578
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 6 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
142 Temple St. 206
New Haven, CT 06510
USA
Email Address
Overview
Soft Tissue Regeneration has developed and preliminarily tested a potential breakthrough technology for soft tissue regeneration of the anterior cruciate ligament of the knee.
Profile
Soft Tissue Regeneration LinkedIn Company Profile
Social Media
Soft Tissue Regeneration Company Twitter Account
Company News
Soft Tissue Regeneration News
Facebook
Soft Tissue Regeneration on Facebook
YouTube
Soft Tissue Regeneration on YouTube

Management Team

Title
Name
Email & Social
Co-Founder
Michael Aronson
  Michael Aronson LinkedIn Profile  Michael Aronson Twitter Account  Michael Aronson News  Michael Aronson on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/7/2016: Elysium Health venture capital transaction
Next: 12/8/2016: RoosterBio venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on all VC transactions involving tech companies. All VC database entries on this site come from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary